Evidence map›Paper›PMID 21925292›Full record

ReviewBiochimica et biophysica acta2012

Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Vivian Hook, Lydiane Funkelstein, Jill Wegrzyn, Steven Bark, Mark Kindy, Gregory Hook

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Functional genomics identify causal variant underlying the protective CTSH locus for Alzheimer's disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  8. iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes.International journal of molecular sciences · 2022
    Article
  9. The Key Role of Lysosomal Protease Cathepsins in Viral Infections.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Assessing the role ofJournal of oral microbiology · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Vivian HookSkaggs School of Pharmacy and Pharmaceutical Sciences, Dept. of Neurosciences, Univ. of Calif., San Diego, USA. vhook@ucsd.edu
Lydiane Funkelstein
Jill Wegrzyn
Steven Bark
Mark Kindy
Gregory Hook
University of Montana · USAmerican Life Science Pharmaceuticals (United States) · USMedical University of South Carolina · US

Funding

Trafficking of catecholamine storage vesicle proteinsP01HL058120 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHORK, NICHOLAS JOSEPH · 1999 to 2009
$18.5M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Serpin Protease Inhibitors &Opioid NeuropeptidesR01NS024553 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H. · 1987 to 2006
$2.5M
BIOSYNTHESIS OF ENKEPHALIN OPIOID PEPTIDESR01DA004271 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 1987 to 2009
$2.5M
POMC Processing Beta-Endorphin-Related Opioid PeptidesR01MH077305 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H · 2006 to 2010
$1.6M
Development of E64d for Alzheimer's diseaseR44AG032784 · NIA · AMERICAN LIFE SCIENCE PHARMACEUTICALS · PI HOOK, GREGORY R · 2008 to 2011
$1.3M
Cathepsin L in the Biosynthesis of Enkephalins and beta-Endorphin Opioid PeptidesK01DA023065 · NIDA · UNIVERSITY OF HOUSTON · PI BARK, STEVEN · 2008 to 2012
$735k
Inhibitors of beta-Amyloid Production in Alzheimer'sR21AG027446 · NIA · AMERICAN LIFE SCIENCE PHARMACEUTICALS · PI HOOK, GREGORY R · 2006 to 2007
$322k
NHLBI NIH HHS P01 HL058120NHLBI NIH HHS P01HL58120NIA NIH HHS AG027446NIA NIH HHS IR44AG032784NIA NIH HHS R21 AG027446NIA NIH HHS R44 AG032784NIDA NIH HHS K01 DA023065NIDA NIH HHS K01DA023065NIDA NIH HHS R01 DA004271NIDA NIH HHS R01DA04271NIMH NIH HHS R01 MH077305NIMH NIH HHS R01MH077305NINDS NIH HHS P30 NS047101NINDS NIH HHS P30NS047101NINDS NIH HHS R01 NS024553NINDS NIH HHS R01NS24553
6 · The paper itself

Abstract

Recent new findings indicate significant biological roles of cysteine cathepsin proteases in secretory vesicles for production of biologically active peptides. Notably, cathepsin L in secretory vesicles functions as a key protease for proteolytic processing of proneuropeptides (and prohormones) into active neuropeptides that are released to mediate cell-cell communication in the nervous system for neurotransmission. Moreover, cathepsin B in secretory vesicles has been recently identified as a β-secretase for production of neurotoxic β- amyloid (Aβ) peptides that accumulate in Alzheimer's disease (AD), participating as a notable factor in the severe memory loss in AD. These secretory vesicle functions of cathepsins L and B for production of biologically active peptides contrast with the well-known role of cathepsin proteases in lysosomes for the degradation of proteins to result in their inactivation. The unique secretory vesicle proteome indicates proteins of distinct functional categories that provide the intravesicular environment for support of cysteine cathepsin functions. Features of the secretory vesicle protein systems insure optimized intravesicular conditions that support the proteolytic activity of cathepsins. These new findings of recently discovered biological roles of cathepsins L and B indicate their significance in human health and disease. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.

Indexed as

Alzheimer DiseaseAmino Acid SequenceAmyloid beta-PeptidesAnimalsCathepsin BCathepsin LCathepsinsCysteine ProteasesHumansModels, BiologicalMolecular Sequence DataNeurotransmitter AgentsPeptidesProteolysisSecretory VesiclesAmyloid beta-PeptidesCathepsin BCathepsin LCathepsinsCysteine ProteasesNeurotransmitter AgentsPeptides

Identifiers

PMID21925292
PMCPMC3232284
OpenAlexW2034718998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.